Appeal No. 2004-1259 Application No. 09/832,355 Claims 1, 9, 12 and 17 are illustrative of the claims on appeal and read as follows: 1. A fusion protein comprising a first non-heparin-binding VEGF-A peptide portion, or a peptide portion that exhibits at least about 80% homology to a VEGF-A peptide portion, and a second non-VEGF peptide portion covalently associated with the first peptide portion, which first and second peptide portions separately promote angiogenesis or bone growth, and wherein the second peptide portion lacks a collagen binding domain. 9. The fusion protein of claim 1, wherein the fusion protein is more angiogenic than a protein consisting essentially of the first peptide portion and/or is more angiogenic than a protein consisting essentially of the second peptide portion. 12. The fusion protein of claim 9, wherein blood vessels resulting from administration of the fusion protein to a mammalian host are associated with more smooth muscle cells, a greater concentration of smooth muscle cells, more endothelial cells, a greater concentration of endothelial cells, or any combination thereof, than blood vessels resulting from administration of a protein consisting essentially of the first peptide portion. 17. The fusion protein of claim 1, wherein the second peptide portion comprises a peptide which promotes blood vessel wall maturation, blood vessel wall dilatation, blood vessel remodeling, extracellular matrix degradation, decreases blood vessel permeability, or any combination thereof. The references cited by the examiner are: Gill et al. (Gill) 6,291,667 Sept. 18, 2001 Rockwell et al. (Rockwell) 5,874,542 Feb. 23, 1999 Davis et al. (Davis) WO 00/37642 Jun. 29, 2000 Yoon et al. (Yoon), “Cloning and Cytotoxicity of Fusion Proteins of EGF and Angiogenin,” Life Sciences, Vol. 64, No.16, pp. 1435-1445 (1999) References cited by Appellants are: N. Ferrara, “VEGF: an update on biological and therapeutic aspects,” Curr. Opinion Biotech., Vol. 11, pp. 617-624 (2000) 2Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007